Human medicines European public assessment report (EPAR): Afinitor, everolimus, Date of authorisation: 02/08/2009, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Yondelis, trabectedin, Date of authorisation: 17/09/2007, Revision: 29, Status: Authorised

Agenda - Combination products operational group, In vitro diagnostics (IVD) stream, 21 October 2026

European Sales and Use of Antimicrobials for Veterinary Medicine (ESUAvet) annual surveillance reports

Terms of reference for the European Sales and Use of Antimicrobials for veterinary medicine (ESUAvet) network

Human medicines European public assessment report (EPAR): Spectrila, asparaginase, Date of authorisation: 14/01/2016, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Capvaxive, pneumococcal polysaccharide conjugate vaccine (21-valent), Date of authorisation: 24/03/2025, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): mNexspike, COVID-19 mRNA vaccine, Date of authorisation: 12/02/2026, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Orphacol, cholic acid, Date of authorisation: 12/09/2013, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Delstrigo, doravirine,lamivudine,tenofovir disoproxil, Date of authorisation: 22/11/2018, Revision: 15, Status: Authorised